Danette L. Daniels

7.0k citations
46 papers · 4.1k indexed · 1 hit paper · h-index 29
    • Protein Degradation and Inhibitors 23
    • Ubiquitin and proteasome pathways 15
    • Histone Deacetylase Inhibitors Research 7
    • RNA Research and Splicing 7
    • RNA modifications and cancer 6
    • Genomics and Chromatin Dynamics 5
    • Epigenetics and DNA Methylation 4
  • Hematology top 2%
    • Multiple Myeloma Research and Treatments 9
  • Oncology top 5%

Danette L. Daniels

46 papers receiving 4.1k citations

Hit Papers

Trivalent PROTACs enhance protein degradation via combine...168202120262022202450100150

Peers

Danette L. Daniels
Comparison fields: 5 of 101
  • Molecular Biology 3.7k
  • Hematology 523
  • Oncology 788
  • Cancer Research 306
  • Cell Biology 283
Replace Roy M. Pollock with:
Roy M. Pollock United States
David C. Dalgarno United States
Sheri L. Moores United States
Michael R. Schlabach United States
Dennis L. Buckley United States
Robert J. Sims United States
Fuad Bahram Sweden
Rosa Bernardi Italy
Shanhai Xie United States
Nicolas H. Thomä Switzerland
Danette L. Daniels relative to Roy M. Pollock United States Roy M. Pollock's profile →
Citations per field
00.5×1.5×1.8×
Roy M. Pollock · 1×
Citations per year

Countries citing papers authored by Danette L. Daniels

Since Specialization
Citations

This map shows the geographic impact of Danette L. Daniels's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danette L. Daniels with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danette L. Daniels more than expected).

Fields of papers citing papers by Danette L. Daniels

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danette L. Daniels. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danette L. Daniels. The network helps show where Danette L. Daniels may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Danette L. Daniels, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Danette L. Daniels Line = papers co-authored together Danette L. Daniels links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20237
2 202314
3 20238
4 202249
5 202196
6
Trivalent PROTACs enhance protein degradation via combined avidity and cooperativitybreakdown →
2021168
7 202110
8 201970
9 201854
10 201837
11 201670
12 2016120
13 2015111
14 2015134
15 2015196
16 20148
17 201369
18 2013387
19 2002145
20 1996107

About Danette L. Daniels

Danette L. Daniels is a scholar working on Hematology, Molecular Biology and Cell Biology, having authored 46 papers that have together received 4.1k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (23 papers), Ubiquitin and proteasome pathways (15 papers), Multiple Myeloma Research and Treatments (9 papers), Histone Deacetylase Inhibitors Research (7 papers), RNA Research and Splicing (7 papers), RNA modifications and cancer (6 papers), Genomics and Chromatin Dynamics (5 papers) and Epigenetics and DNA Methylation (4 papers). The work is most often cited by research in Molecular Biology (3.7k citations), Hematology (523 citations) and Oncology (788 citations). Danette L. Daniels has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include William I. Weis, Marjeta Urh, Kristin M. Riching, Marie K. Schwinn, Jacqui Méndez, Matthew B. Robers, Sarah D. Mahan, Thomas Machleidt, Keith V. Wood and Nancy E. Murphy. Their work appears in journals such as Journal of Visualized Experiments, Cell, Molecular Cell, Nature Communications and Trends in Pharmacological Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026